Back to trial details

Intake questionnaire

A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

Applying to Great Lakes Clinical Trials - Andersonville · Chicago, Illinois

Answer a few short questions to share with the research team.

0 of 4 answered

1. Are you 55 years old or older?
2. Have you been diagnosed with Alzheimer Disease?
3. Are you currently pregnant or breastfeeding?
4. Are you able to travel to Chicago for study visits?